Philippa M Musoke

Summary

Publications

  1. ncbi Severe malnutrition and metabolic complications of HIV-infected children in the antiretroviral era: clinical care and management in resource-limited settings
    Philippa M Musoke
    Department of Paediatrics and Child Health, Makerere University, Kampala, Uganda
    Am J Clin Nutr 94:1716S-1720S. 2011
  2. ncbi Human immunodeficiency virus infection and cerebral malaria in children in Uganda: a case-control study
    Peace D Imani
    Department of Paediatrics and Child Health, School of Medicine, College of Health Sciences, Makerere University, P O Box 7072, Kampala, Uganda
    BMC Pediatr 11:5. 2011
  3. ncbi Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children
    Philippa M Musoke
    Department of Paediatrics and Child Health, Makerere University, Kampala, Uganda
    J Acquir Immune Defic Syndr 49:171-8. 2008
  4. ncbi Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study
    Philippa M Musoke
    Department of Paediatrics and Child Health, Makerere University, Kampala, Uganda
    BMC Pediatr 10:56. 2010
  5. ncbi Response to antiretroviral therapy in HIV-infected Ugandan children exposed and not exposed to single-dose nevirapine at birth
    Philippa M Musoke
    Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    J Acquir Immune Defic Syndr 52:560-8. 2009
  6. ncbi Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda
    Francis A Mmiro
    Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    J Acquir Immune Defic Syndr 52:32-9. 2009
  7. ncbi Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated
    Jim Aizire
    Makerere University, Johns Hopkins University Research Collaboration, Kampala, Uganda
    AIDS 26:325-33. 2012
  8. ncbi Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infants
    Irene R Lubega
    Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    J Acquir Immune Defic Syndr 55:58-64. 2010
  9. ncbi Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda
    Benon B Asiimwe
    Department of Medical Microbiology, Makerere University College of Health Sciences, P O Box 7072, Kampala, Uganda
    BMC Infect Dis 13:88. 2013
  10. ncbi High incidence of pulmonary tuberculosis in children admitted with severe pneumonia in Uganda
    Josephine M Nantongo
    Directorate of Paediatrics and Child Health, Mulago National Referral Hospital, Kampala, Uganda
    BMC Pediatr 13:16. 2013

Research Grants

  1. DEVELOPING SUSTAINABLE HIV CLINICAL TRIALS RESEARCH CAPACITY IN UGANDA
    Philippa Musoke; Fiscal Year: 2009

Collaborators

Detail Information

Publications10

  1. ncbi Severe malnutrition and metabolic complications of HIV-infected children in the antiretroviral era: clinical care and management in resource-limited settings
    Philippa M Musoke
    Department of Paediatrics and Child Health, Makerere University, Kampala, Uganda
    Am J Clin Nutr 94:1716S-1720S. 2011
    ....
  2. ncbi Human immunodeficiency virus infection and cerebral malaria in children in Uganda: a case-control study
    Peace D Imani
    Department of Paediatrics and Child Health, School of Medicine, College of Health Sciences, Makerere University, P O Box 7072, Kampala, Uganda
    BMC Pediatr 11:5. 2011
    ..There is still a paucity of data on the association between HIV-1 infection and cerebral malaria in children. The aim of this study was to determine whether HIV-1 infection is a risk factor for cerebral malaria in children...
  3. ncbi Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children
    Philippa M Musoke
    Department of Paediatrics and Child Health, Makerere University, Kampala, Uganda
    J Acquir Immune Defic Syndr 49:171-8. 2008
    ..To determine the utility of total lymphocyte count (TLC) in predicting the 12-month mortality in HIV-infected Ugandan children and to correlate TLC and CD4 cell %...
  4. ncbi Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study
    Philippa M Musoke
    Department of Paediatrics and Child Health, Makerere University, Kampala, Uganda
    BMC Pediatr 10:56. 2010
    ..We documented the weight and height responses in HIV infected Ugandan children on highly active antiretroviral therapy and determined clinical factors associated with successful treatment outcomes...
  5. ncbi Response to antiretroviral therapy in HIV-infected Ugandan children exposed and not exposed to single-dose nevirapine at birth
    Philippa M Musoke
    Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    J Acquir Immune Defic Syndr 52:560-8. 2009
    ..To compare the response to a nevirapine (NVP)-based highly active antiretroviral therapy (HAART) in HIV-infected Ugandan children, exposed and nonexposed to single-dose NVP (sd NVP) at birth...
  6. ncbi Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda
    Francis A Mmiro
    Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    J Acquir Immune Defic Syndr 52:32-9. 2009
    ..To determine the predictors for early versus later (breastfeeding) transmission of HIV-1...
  7. ncbi Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated
    Jim Aizire
    Makerere University, Johns Hopkins University Research Collaboration, Kampala, Uganda
    AIDS 26:325-33. 2012
    ..Nevirapine and cotrimoxazole are associated with hematologic toxicities and skin-rash. Safety of their concurrent use for prophylaxis over extended periods among HIV-exposed uninfected infants has not been previously assessed...
  8. ncbi Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infants
    Irene R Lubega
    Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    J Acquir Immune Defic Syndr 55:58-64. 2010
    ....
  9. ncbi Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda
    Benon B Asiimwe
    Department of Medical Microbiology, Makerere University College of Health Sciences, P O Box 7072, Kampala, Uganda
    BMC Infect Dis 13:88. 2013
    ....
  10. ncbi High incidence of pulmonary tuberculosis in children admitted with severe pneumonia in Uganda
    Josephine M Nantongo
    Directorate of Paediatrics and Child Health, Mulago National Referral Hospital, Kampala, Uganda
    BMC Pediatr 13:16. 2013
    ..Moreover, TB is associated with high morbidity and mortality among such children. We conducted this study to establish the burden of pulmonary TB in children admitted with severe pneumonia in our setting...

Research Grants1

  1. DEVELOPING SUSTAINABLE HIV CLINICAL TRIALS RESEARCH CAPACITY IN UGANDA
    Philippa Musoke; Fiscal Year: 2009
    ..The Planning grant will help address NIH efforts commitment to capacity strengthening and training of international researchers to carry out HIV research. ..